Professional Documents
Culture Documents
AccuLine Company Profile
AccuLine Company Profile
AccuLine Company Profile
AccuLine
Preventing the next Heart Attack
https://acculine-medical.com
About
AccuLine was founded with the vision to save the lives of millions of people worldwide by preventing the next heart attack. AccuLine is
developing CORA – an accurate, non-invasive, swift, and cost-effective examination for early detection of CAD, designed to replace the
inaccurate, time-consuming, and labor-intensive stress test examinations. AccuLine has received grants from Google and the Israeli
Innovation Authority, and among its shareholders are Mayo Clinic, eHealth Ventures and Maccabi Healthcare Services.
Geographical markets
North America
Products
CORA
Funding
Total funding Market cap Last funding Funding stage Total rounds Investors
$4.16M Undisclosed $2.1M Seed 5 4
The Team
Moshe Barel Aaron Freimerman
Co-founder & CEO CMO
Company lifecycle
Affiliation Undisclosed
Jan 2022
Hub Name
eHealth Ventures
Pre-Seed $375K
3 Investors Mar 2022
Grant $930K
Mar 2022
Affiliation Undisclosed
Oct 2022
Hub Name
NVIDIA Inception
Affiliation Undisclosed
Nov 2022
Hub Name
Seed $2.1M
3 Investors Mar 2024
Grant $600K
Mar 2024
Grant $150K
Mar 2024
Locations
Israel
Park Ofer, פתח תקווה,9 הפסגות, Israel
Sectors